The Texas Tech University Health Sciences Center (TTUHSC) and UMC Health System announced the appointment of Tyler J. Mouw, M.D., as medical director of the UMC TLC Foundation Cancer Center.

Mouw, who previously served as interim medical director of the cancer center, also serves as division chief of surgical oncology and hepatobiliary surgery at the TTUHSC School of Medicine, chief of surgical oncology at Texas Tech Physicians and the medical director of oncologic surgery at UMC."On behalf of UMC Health System, it is my pleasure to announce Dr. Tyler Mouw as medical director of UMC's TLC2 Foundation Cancer Center," UMC President and CEO Mark Funderburk said.

"Dr. Mouw is a gifted surgical oncologist within the Department of Surgery at the TTUHSC School of Medicine. Dr. Mouw cast a vision to bring innovative treatment to our community, not previously available outside larger cities. Dr. Mouw offers cancer patients a compassionate spirit paired with the latest in technology including - The HIPEC (Hyperthermic Intraperitoneal Chemotherapy) procedure for abdomen cancer and this year - Histotripsy, a non-invasive procedure using focused sound waves to destroy and liquify liver tumors. Dr. Mouw leads a tremendous team of cancer specialists with a singular goal in mind - to provide an exceptional patient experience, founded on clinical expertise, available close to home."Through the partnership between UMC and TTUHSC, the UMC TLC2 Foundation Cancer Center connects patients in West Texas and Eastern New Mexico with cutting-edge cancer research and innovative treatments through adult and pediatric clinical trials.